Shiraz University of Medical Sciences (sponsor), 2019-02-24: Iranian randomised, double-blind phase 3 trial registered by Shiraz University of Medical Sciences comparing 50% DMSO solution with 0.5% tretinoin cream in primary localised cutaneous amyloidosis. Target 10 patients, status recruiting; no results posted.
Comparing the efficacy of 50% dimethyl sulfoxide solution versus topical tretinoin 0.5% cream in patients with cutaneous amyloidosis
Scientific title field of the registry record
Shiraz University of Medical Sciences (sponsor), 2019-02-24: Iranian randomised, double-blind phase 3 trial registered by Shiraz University of Medical Sciences comparing 50% DMSO solution with 0.5% tretinoin cream in primary localised cutaneous amyloidosis. Target 10 patients, status recruiting; no results posted. C8 Iranian trial. Record fields: phase 3; randomised, double blind, no placebo, parallel assignment; target sample size 10; first enrolment 2019-03-21; recruitment status 'Recruiting' at last refresh (25 March 2019). Country: Iran. Funder: Shiraz University of Medical Sciences (public). Comparator: topical tretinoin 0.5%. Registered, no results. The record notes the trial is bilateral (right/left side allocation), so each patient serves as their own control. Also filed as DMB-79 (claims C8, C9).
